ChatGPT, OpenAI’s text-generating AI chatbot, has taken the world by storm since its launch in November 2022. What started as a tool to supercharge productivity through writing essays and code ...

ACELYRIN, Inc., a Los Angeles area-based, late-stage clinical biopharma, with additional operations in the San Francisco Bay area, has announced it is acquiring privately held ValenzaBio – which ...

Chatbot can analyse health-care imagery, such as PDFs of test results, to accurately diagnose a range of medical conditions. Mariana Lenharo Research Highlight | 07 May 2025 ...